Results 111 to 120 of about 43,490 (164)

Assessing the predictability of isocitrate dehydrogenase mutational status in glioma patients using imaging features. [PDF]

Surg Neurol Int
Goncalves JM, Miranda A, Silva C, Carvalho B, Polónia P, Linhares P.   +5 more
europepmc   +1 more source

A novel MRI diffusion metric 'slow diffusion coefficient' (SDC) for diagnosing isocitrate dehydrogenase (IDH) genotype in diffuse gliomas: initial promising results. [PDF]

BMC Med Imaging
Zheng WY, Shi YT, He YY, Lin RL, Xiao BH, Jiang RF, Wáng YXJ.   +6 more
europepmc   +1 more source

Characteristics of [¹⁸F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification - a retrospective analysis. [PDF]

Eur J Nucl Med Mol Imaging
Barci E, Mair MJ, Reis J, Müller K, Isakaj J, Istrefi E, von Polenz I, Siegmund SC, Kaiser L, Preusser M, Schichor C, Thon N, Harter P, von Baumgarten L, Forbrig R, Albert NL.   +15 more
europepmc   +1 more source

Isocitrate dehydrogenase-mutant astrocytoma in persons aged 55 years and older: Survival differences versus the young. [PDF]

J Neuropathol Exp Neurol
Siddiq Z, Gilani A, Ung TH, Kleinschmidt-DeMasters BK.   +3 more
europepmc   +1 more source

<i>C. elegans</i> Cytoplasmic Isocitrate Dehydrogenase Neomorphic G98N and R133H Mutants Produce the Oncometabolite 2-Hydroxyglutarate. [PDF]

Int J Mol Sci
Bouchard M, McAllister A, Bourlett NS, Hoyt C, Calcul L, Walstrom KM.   +5 more
europepmc   +1 more source

Clinical and Prognostic Implications of Isocitrate Dehydrogenase Mutation in Gliomas Within a Latin American Public Oncology System: Insights From a Retrospective Panamanian Cohort. [PDF]

Cureus
Palma-García F, Abrego A, O Neill A, Lorenzo-Luaces R, Salgado M, Chong P, Castillo J, Arauz RE.   +7 more
europepmc   +1 more source

Study on the phosphorylation of NAD⁺-specific isocitrate dehydrogenase in the pathogenic bacteria <i>Stenotrophomonas maltophilia</i> and <i>Xanthomonas sacchari</i>. [PDF]

J Enzyme Inhib Med Chem
Tian Q, Zhang Y, Pan C, Wang L, Qin N, Jiang Z, Li C, Cao Z, Zhu G, Wang P.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Role of isocitrate dehydrogenase in glioma

Expert Review of Neurotherapeutics, 2011
Recently, the isocitrate dehydrogenase (IDH) enzymes have become a focal point for research aimed at understanding the biology of glioma and identifying novel targets for therapy. Following the publication of a landmark genetic sequencing study in 2008, which identified IDH1 as a frequently mutated gene in glioblastoma, much work has been carried out ...
Minesh Mehta, Brian Alexander
exaly   +3 more sources

The isocitrate dehydrogenase from cyanobacteria

Archives of Microbiology, 1983
The present communication describes the properties of isocitrate dehydrogenase in crude extracts from the unicellular Anacystis nidulans and from heterocysts and vegetative cells of Nostoc muscorum and Anabaena cylindrica. The activity levels of this enzyme are much higher in heterocysts than in vegetative cells of N. muscorum and A.
Hermann Bothe, Bothe Hermann
exaly   +3 more sources